Framework Reassesses Radiation Dose Constraints for IDH-Wildtype Glioblastoma Treatment
Radiation oncologists propose a structure-specific framework to evaluate intracranial dose constraints and document target-volume trade-offs in IDH-wildtype glioblastoma radiotherapy.




